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The thermodynamic behavior of representative short (UQ2), middle (UQ4 and UQ6) and long-chain (UQ10) ubiquinones (UQ) mixed with
dipalmitoyl-phosphatidylcholine (DPPC) was studied in monolayers at the air–water interface. The influence of isoprenoid chain-length of UQ on
miscibility of both lipids was investigated by analysis of surface pressure-area isotherms and using fluorescence microscopy. Analysis of excess
areas (Aex) and free energies of mixing (ΔGm), calculated from compression isotherms in the full range of ubiquinones concentrations, has given
evidences for UQ-rich constant-size (UQ6, UQ10) or less growth limited (UQ2, UQ4) microdomains formation within mixed films. Fluorescence
microscopy observation revealed that ubiquinones are preferentially soluble in the expanded phase. When lateral pressure increased, concomitant
evolutions of Aex and ΔGm parameters, and composition dependence of collapse surface pressures, argue for an evolution towards a total
segregation, never reached due to expulsion of ubiquinones from the film. The possible significance of these observations is discussed in relation
to ubiquinones organization and similar chain length effects in membranes.
© 2006 Elsevier B.V. All rights reserved.Keywords: Mixed monolayer; Ubiquinone; Fluorescence microscopy; Molecular interaction; Miscibility1. Introduction
Ubiquinones are known to act as mobile lipophilic redox
components of transmembrane electrons transport systems of
eukaryotic and prokaryotic organisms. These compounds, also
named coenzymes Q, consist of a redox-active 2,3-dimethoxy-
5-methylbenzoquinone ring with a hydrophobic isoprenoid side
chain in the 6 position. Ubiquinones (UQn) differ from one to
another in the length of their side chain as indicated by a number
(n) following the name, which is ranging between 2 and 10
isoprene units (2-methyl-2-butene) [1,2]. Thus ubiquinone 10
(UQ10) indicates a quinone with a side chain containing 10
isoprene units or 50 carbon atoms. They have been isolated for
the first time in 1957 from bovine heart mitochondria by F.L.⁎ Corresponding author. Tel.: +33 1 42 86 20 46; fax: +33 1 42 86 20 85.
E-mail address: Sophie.Bernard@univ-paris5.fr (S. Bernard).
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doi:10.1016/j.bbamem.2006.03.015Crane and have been described the same year by Crane et al. [3],
Morton et al. [4], Ernster and Dallner [5].
Ubiquinone 10 is the major physiological form of ubiqui-
nones found in animals and humans. Its main function is to act as
a coenzyme in the respiratory chain of the inner mitochondrial
membranes by laterally transferring electrons from the complex
I (or complex II) to complex III and transporting protons across
the membrane by transverse diffusion, as described by P.
Mitchell in 1976 when he introduced his famous “Q cycle” [6,7].
Now, it is well established that, in addition to these bioenergetic
functions, ubiquinones, in their reduced form (ubiquinols), serve
also as lipid-soluble antioxidants. Indeed, as suggested in 1961
by Kaufmann and Garloff [5,8], an antioxidant function of UQ
was found to protect against lipid peroxidation in the membrane,
to prevent DNA damage and serum low-density lipoproteins
peroxidation [5]. Moreover, ubiquinones can regenerate vitamin
E [9], another powerful antioxidant. Ubiquinones could also
have a prooxidant action [10] since the reaction of the semi-
quinone radical with O2 produces a superoxide radical. Lastly,
roles in the control of cell growth [11–13] and apoptosis [14,15]
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to regulate inhibition or activation of apoptosis by their pro- and
antioxidant properties or by direct interactions with systems
known to control this cell-death process.
The ever-increasing use of ubiquinones for the treatment of a
great variety of pathologies, including myopathies, [16–20]
cardiovascular diseases [21–23] and age related degenerative
diseases, [24–26] has considerably stimulated medical interest
in these natural molecules. Although UQ10 is the human homo-
logue, some clinical studies showed that the short-chain ana-
logues have a greater medical efficiency than exogenous UQ10
[27]. Moreover, several studies have pointed out that complex I
of the mitochondrial respiratory chain has two distinct anchoring
sites for short-chain and long-chain ubiquinones [28–30]. This
result suggests that the biological action of ubiquinones could
depend on their lateral chain length.
Hence, studying the localization and the molecular organi-
zation of ubiquinones in membrane is essential for understand-
ing how their roles in biological membranes, and then their
medical efficiency, could depend on their chain length. Indeed,
the role of the polyisoprene domain in UQ mobility, redox
reactions, location within the membrane is not unequivocally
explained. In a previous paper [31], we used mixed monomo-
lecular films containing phospholipids and UQ2 or UQ10. Our
conclusions had pointed out that UQ2 would have their benzo-
quinone rings located nearer the headgroup of phospholipids,
their side chain parallel to phospholipids acyl chain, while UQ10
would rather lie parallel to the membrane plane in the bilayer
center, as stated by some authors using bilayers as model
membranes. Indeed, 1H-NMR study [32] and NMR measure-
ments of 13C-labeled ubiquinones [33] have both shown that
short-chain ubiquinones (UQ2, UQ3) are located near the bilayer
surface, while UQ10 seems entirely located near the bilayer
midplane. Several differential scanning calorimetry (DSC) studies
have allowed drawing the same conclusions by following ubi-
quinones influence on phospholipids vesicles thermodynamic
parameters ([34–36] and Roche, Y. et al., unpublished data). In
contrast, other workers using fluorescence anisotropy techniques
have suggested that the UQ10 benzoquinone ring interacts with
the phospholipids polar heads, while their side chain would
remain anchored to the hydrophobic bilayer midplane [37]. Based
on linear dichroism and fluorescence quenching experiments,
Lenaz et al. [38], Samori et al. [39] have studied the orientation of
ubiquinones in bilayers and concluded that, even if they tend to
oscillate between the two bilayer surfaces, long-chain ubiqui-
nones may spend statistically longer times at the midplane. More
recently, Hauss et al. [40] have shown that the polyisoprene
domain ofUQ10, like that of squalane, [41] lies in the center of the
hydrophobic core parallel to the membrane plane and not parallel
to the lipid chains. Thus, quinone polyisoprenoids may inhibit
proton leakage in addition to their other biological roles.
The present study aims to provide new insights about the
influence of chain-length on the organization of ubiquinones in
monolayers. We report here a systematic and comparative study
of four ubiquinones and their mixing with dipalmitoyl-phos-
phatidylcholine (DPPC) at the air–water interface, using the film
balance technique. UQ with two (UQ2), four (UQ4), six (UQ6)and ten isoprene units (UQ10) have been used as representative
of short to long-chain quinones. Information about miscibility of
the components and thermodynamical data were deduced from
analysis of surface pressure-area isotherms. Observation of
mixed monolayers by epifluorescence microscopy has permitted
us to study the changing sizes and shapes of condensed domains
as a function of the molar fraction of ubiquinone.
2. Materials and methods
2.1. Materials
Ubiquinone 2 (UQ2), ubiquinone 6 (UQ6) and ubiquinone 10 (UQ10) were
purchased from Sigma Aldrich (France), whereas ubiquinone 4 (UQ4) was
supplied by Fluka (France). All the ubiquinones were used without further
purification. L-α-dipalmitoyl phosphatidylcholine (DPPC) was of the purest
available quality from Sigma. The fluorescent probe, 2-(6-(7-nitrobenz-2-oxa-1,
3-diazol-4-yl)amino)hexanoyl-1-hexadecanoyl-sn-glycero-3-phosphocholine
(NBD-PC) was obtained fromMolecular Probes Inc. (USA). Chloroform was of
analytical grade from Fisher Scientific Co. (France). The subphase was pure
water treated on an Elgastat UHQ 2 system (resistivity of 18 MΩcm). Stock
solutions of the four ubiquinones and DPPC, 10−3 M or 2.5×10−4 M, were
prepared in chloroform, or chloroform/methanol 90:10 (v:v) for UQ10, and
spread separately or mixed in the wanted molar ratios.
2.2. Surface-pressure isotherms
Isotherms were performed with a Nima model 611M trough (Nima
Technologies, England). The surface pressure was measured by the Wilhelmy
plate method. The films were spread with Hamilton 1705 RN or 1710 RN
microsyringes. The film compression started at least 20 min after spreading the
lipids to allow solvent evaporation and was achieved at a speed of 4.5 Å2/min/
molecule. All experiments were performed at pH 5.7 and at a temperature of 22 °C.
All surface pressure-area isotherms presented here are the average of three to five
experiments. Data analysis was done with Origin 5.0 from Microcal Software.
2.3. Epifluorescence microscopy
Visualization of monolayers was done by means of an Olympus-BX30
microscope, set on a Riegler and Kirsten Langmuir trough. Excitation of the
probe is achieved using high-pressure mercury lamp. Discrimination of
excitation (470 nm) and emission (530 nm) fluorescence from the dye (NBD-
PC) is regulated by dichroic mirrors and interchangeable cut-off filters. An AIS
(MXRi2) video camera with an image intensifier which allows a very high
sensitivity (10−6 Lux) enables us to visualize the monolayer and to record
images. These experiments were also performed at a temperature of 22 °C and at
pH 5.7. Mixtures were prepared from a chloroform solution of DPPC containing
the wanted proportions of ubiquinone and 0.5 mol% NBD-PC. The probe is
excluded from densely packed areas of lipid, providing contrast between lipid
phases. Images were recorded during the continuous low speed (0.2 Å2/min/
molecule) symmetric compression of the monolayer and their features were
analyzed using digital image analysis software OPTIMAS 5.1 (Optimas
Corporation). The percentage of dark region was estimated by division of the
total amount of probe-excluded regions by the total area of a frame. Our
homemade acquisition software allows surface pressure to be measured
simultaneously with image grabbing. The accuracy of surface pressure
measurements is ±0.5 mN/m.3. Results
3.1. Pure UQn monolayers
The surface pressure-area isotherms for pure ubiquinones
with different side-chain length performed at 22 °C on a water
Fig. 2. (A) Variation of the compressibility as a function of the number of
isoprene units. Values of κ were determined at 5 mNm−1 (●) and at 10 mNm−1
(○) from isotherms of pure UQ monolayers. (B) Collapse surface pressures of
pure UQ monolayers as a function of the number of isoprene units, determined
from the inflection points on the compression isotherms.
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of forming monolayers at the air/water interface. The curves do
not show the presence of the transition from liquid-expanded to
liquid condensed state as observed in pure DPPC monolayers.
As the number of isoprene units in the molecules increases, the
surface pressure-area curves shift, at a given surface pressure
below the collapse, to greater values of area per molecule. For
surface pressure up to 3 mN/m, isotherms of UQ6 and UQ10
overlap. UQ6 occupies a greater molecular area than UQ4
below 12 mN/m.
The limiting areas per molecules, obtained by extrapolation
of the linear parts on the isotherms to the abscissa, of UQ2,
UQ4, UQ6 and UQ10 are 48.05, 59.35, 65.94 and 70.82 Å2,
respectively. The limiting areas increase with the side chain
length. The addition of two isoprene units clearly causes more
pronounced changes in the area for short homologues than for
the long ones.
The compressibility κ was calculated at 5 and 10 mN/m
according to Eq. (1) (where A is the molecular area in the film at
a fixed surface pressure) and plotted in Fig. 2A as a function of
the number of isoprene units.
j ¼  1
A
BA
Bp
 
T
: ð1Þ
At 5 mN/m, compressibilities of UQ2, UQ4 and UQ10 are
close to that of DPPC (about 32 m/N), while such a κ value
reaches at 10 mN/m for UQ6. At this surface pressure, the
variation of κ of UQ2, UQ4 and UQ6 seems to be more sensitive
to the chain length, even if κ of UQ10 is close to that of UQ6.
The collapse pressures πc of the monolayer, corresponding to
the surface pressures at the transition point from monolayer to
three-dimensional multilayer films, were determined from the
inflection points on the curves and are presented in Fig. 2B as a
function of the number of isoprene units. Among the four
ubiquinones investigated, the most hydrophobic one, UQ10 (ten
isoprene units, i.e., 50 carbon atoms) has formed monolayers
with the lowest collapse pressure. UQ2 shows the highestFig. 1. Compression isotherms of pure UQ monolayers spread on water
subphase (pH 5.7) at 22 °C.collapse pressure as the most polar molecule of the series. As
the length of the side-chain decreases, the monolayers become
more stable to higher pressures. Our data exhibit an exponential
decrease of πc with the number of isoprene units.
For each UQ, the pure film could be compressed to very low
areas (below 20 Å2) without observing a decrease in pressure
(data not shown). This is not consistent with the van der Waals
dimension of a methyl-branched hydrocarbon chain oriented in
close-packed array which is about 45 Å2 [42]. This observation
suggests that a loss of material occurs during the compression:
ubiquinones could be progressively squeezed out of the film.
In order to evaluate the proportion of the material that was
squeezed out from the monolayer at a given surface pressure,
we have investigated the hysteresis of isotherms of pure UQ
monolayers during compression-expansion cycles. In the first
cycle of compression and expansion of the monolayer, negative
hysteresis (i.e., decrease in area at a given pressure between the
compression and the expansion segments of an isocyle) were
Table 1
Percentages of loss of UQ in monolayers at different surface pressure below the
collapse (πc) calculated from two compression-expansion cycles
Compound At πc/4 At πc/2 At πc πc (mN/m)
UQ2 2% 5% 9.2% 29.5
UQ4 1% 3.2% 7% 19.4
UQ6 1% 3% 5.4% 16.4
UQ10 1% 2% 8.5% 11.7
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type of hysteresis is mostly observed [43] and could usually be
attributed to: (i) incomplete dissolution of the sample into the
spreading solvent, (ii) loss of molecules due to partial dissolution
into the subphase, (iii) film collapse or multilayer formation
during compression of the amphiphilic molecules. No pre-
cipitates were detected in the UQ solutions. When we spread
different concentrations of UQ solutions, the surface pressure-
area isotherms were identical. Therefore, explanation (i) is ex-
cluded. To evaluate the percentage of loss of material, we have
examined two consecutive isocycles from the same monolayer,
at three different target pressures: πc/4, πc/2 and πc. In all cases, a
strong dependence of the target pressure (πt) on the hysteresis
was observed. More πt was close to πc, more the hysteresis was
enhanced. The influence of the chain length on the hysteresis
was also observed. For the calculation of the mean percent
content, we used the following formula:
%loss ¼ DA
A
 100 ð2Þ
whereΔA is the decrease in area between the first and the second
compression isotherms and A is the area per molecule obtained
during the first compression at a given surface pressure. As ΔA
varies with the pressure, we used a mean value of ΔA during all
the compression between 0 mN/m and πt. Table 1 lists the
percentages of loss of UQ in the monolayer. The percentage of
loss is found to increase with πt value. In addition, as the chain
length increases, the percentages of loss of UQ are found to
decrease except for UQ10 when the isocycles are performed up
to the collapse pressure.3.2. Mixed DPPC:UQn monolayers
Compression isotherms of DPPC–UQn mixtures, performed
on pure water subphase (pH 5.7) for the following mole fraction
of UQ: 0.01, 0.05, 0.1, 0.25, 0.5, 0.75, are shown in Fig. 3 as a
function of the area per DPPC molecule in the film (i.e., without
accounting UQ area contribution). The characteristic plateau of
the first order transition between liquid expanded LE and liquid
condensed LC states in the isotherm of pure DPPC at a pressure
of about 7 mNm−1 was found to vanish with increasing ubi-Fig. 3. Compression isotherms of mixed DPPC–UQn monolayers spread on
water subphase (pH 5.7) at 22 °C. Surface pressure expressed as a function of the
area per DPPCmolecule for mixtures containing from 1 mol% to 75 mol% UQ2,
UQ4, UQ6 and UQ10. Curve (1) corresponds to the pure DPPC isotherm
(dashed line) and mixtures composition is: 1 mol% (2), 5 mol% (3), 10 mol%
(4), 25 mol% (5), 50 mol% (6) and 75 mol% (7).
Fig. 4. Collapse surface pressures of mixed DPPC–UQmonolayers as a function
of the ubiquinone mole fraction: UQ2 (▾); UQ4 (▴); UQ6 (■); UQ10 (●).
Fig. 5. Excess area of the mixed DPPC–UQ monolayers as a function of the
ubiquinone mole fraction: UQ2 (▾); UQ4 (▴); UQ6 (■); UQ10 (●) at a surface
pressure of 10 mNm−1. Dot lines between the experimental points are simply a
visual guide.
Fig. 6. Differential deviations from ideality ΔAex as a function of surface
pressure for mixed DPPC–UQmonolayers containing 25 mol%: UQ2 (▾); UQ4
(△); UQ6 (■); UQ10 (○).
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trace 5), the plateau has completely disappeared in all cases.
According to the phase rule, if the two components in the
mixed monolayers are miscible, the collapse surface pressure
should vary with composition [44,45]. It is obviously shown in
Fig. 4 that the collapse surface pressures of mixed DPPC-UQn
monolayers varied with composition. The data show a decrease
with the UQ concentration, more pronounced in the case of
UQ2, UQ4 and UQ6 than that observed for UQ10. In this last
case, there are no significant variations of the collapse surface
pressure above 50 mol% UQ10 in the film.
A quantitative analysis of the interaction between DPPC and
UQ is provided by comparing, at a given surface pressure, the
experimental average area per molecule of a mixed monolayer
with that calculated assuming ideality of the mixing through the
additivity rule [46,47] to give the excess area of mixing,
Aex: ¼ A12−ðX1A1 þ X2A2Þ ð3Þ
where A12 is the mean molecular area at a given surface pressure
in the two-component film, X1 and X2 the mole fractions of the
components in the mixed monolayer, and A1 and A2 the mole-
cular areas in pure monolayers of components 1 and 2 at the
same surface pressure. The excess area, Aex, can also be an
indication of miscibility. Indeed, if an ideal mixed monolayer is
formed or the two components are completely immiscible, the
excess area will be zero and a plot of A12 will be linear in X1 at a
given surface pressure. Any deviation would indicate misci-
bility and non-ideality. Fig. 5 illustrates the excess area per
molecule for the DPPC–UQ mixtures studied as a function of
the mole fraction of ubiquinone. The additivity rule enables us
to examine interactions of components in a mixed monolayer
only below the collapse pressure of the component with the
lowest πc. Because of loss of material at higher pressure than
about 13 mNm−1 in the case of UQ10 mixtures, the surface
pressure value of 10 mNm−1 was chosen in order to compare the
behavior of all the quinones. Moreover, the molecular area
expansion was the most important at surface pressures aroundthis value, and the loss of UQ was rather weak. Fig. 5 shows that
positive deviations from ideality are observed for all the
quinones and all compositions at 10 mNm−1. These positive
deviations from ideality indicate an expansion of monolayers
and give strong evidence for repulsive interactions between
ubiquinones and DPPC. Since a linear relationship between
molecular area and composition is not observed, DPPC and
UQn are considered to be miscible and form non-ideal
monolayers at the interface [46]. The maximum deviation of
the experimental data from the theoretical ones for an ideal
mixture is observed at 50 mol% for both UQ6 and UQ10
mixtures. Theses results suggest that the incorporation of UQ6
or UQ10 into a DPPC monolayer may increase interactions
between molecules in the mixed monolayers and the influence
of intermolecular interaction on molecular packing is signifi-
cant. The Aex= f (XUQ) profile is symmetric, i.e., excess area is
proportional to the number of associations between DPPC and
UQn molecules. The relative organization of both components,
the one compared to the other in the mixed film, seems to be
Fig. 7. Total Gibbs free energies of mixingΔGm as a function of composition for
mixed DPPC–UQ monolayers at various surface pressures: (▲) 5 mN/m, (○)
10 mN/m, (■) 25 mN/m, compared with the ideal free energy of mixingΔGideal
(solid line).
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UQ2, the Aex= f (XUQ) profile is asymmetric, deviations from
ideality being maximum at 25 mol% and 10 mol%, respectively.
This suggests that above these contents DPPC:UQn interactions
in mixed films would be minimized due to a change in the
relative organization of both components.
We also introduced the differential deviation from ideality
ΔAex=Aex(π)–Aex(π→0), where Aex(π) and Aex(π→0) are the
excess area per molecule for DPPC:UQ mixtures, respectively, at
a given surface pressure and at π close to zero, monolayers being
assumed in a two-dimensions gaseous state. Variations of ΔAex
with surface pressure for 25 mol% DPPC:UQ mixtures are
depicted (Fig. 6). In all cases, deviation from ideality did not
significantly vary between 1 and 6 mNm−1 and strongly reached
to a maximum within 6–9 mNm−1 range. Interestingly, this
interval corresponds to the LE/LC transition for pure DPPC. This
suggests that miscibility of DPPC and UQn would be strongly
modulated by the physical state of the monolayer, i.e., condensed
or expanded.
Deviations from ideality can also be expressed in term of free
energies of mixing, as in the treatment of mixing in the bulk
state. The values of excess free energy ΔGex were calculated
from the difference between areas under the isotherms of mixed
and pure films for a specified surface pressure, following the
mathematical method of Simpson and according to the Good-
rich approach [48]:
DGexðpÞ ¼
Z p
pY0
ðA12−X1A1−X2A2Þdp ð4Þ
Then, the total free energies of mixing were calculated
according to the following relation:
DGmðpÞ ¼ DGex þ RTðX1lnX1 þ X2lnX2Þ ð5Þ
where R is the gas constant and T is the temperature, and
ΔGideal =RT(X1lnX1+X2lnX2) is the ideal free energy of mixing.
The total free energies of mixing (ΔGex+ΔGideal) were
calculated at different surface pressures. The plot of ΔGm
versus the mole fraction of ubiquinone at various surface pres-
sures is displayed in Fig. 7 with the ideal free energies of mixing
for comparison. The excess free energiesΔGex are positive, i.e.,
ΔGmNΔGideal, at all the studied surface pressures and depend
on the monolayer composition.
The positive ΔGex confirms repulsive interactions between
DPPC and UQn and implies that these interactions are ener-
getically unfavorable. Globally, at given surface pressure and
composition, ΔGm increases with the UQn chain-length, except
for DPPC–UQ10mixtures, whereΔGm values are close to those
of DPPC–UQ6. In addition, shapes of theΔGm= f (XUQ) profiles
are analogous for each kind of mixtures, except for DPPC–UQ2
mixtures, where ΔGm decreases for molar fractions higher than
25%mol, as previously observed for Aex= f (XUQ).Moreover, our
results show that theΔGm values become positively larger as the
surface pressure increases, suggesting that DPPC–UQn inter-
actions are stronger and the mixed monolayers become less
stable at higher surface pressures.3.3. Epifluorescence microscopy of DPPC–UQn monolayers
DPPC:UQn mixtures containing weak ubiquinones molar
fractions (1, 5 and 10 mol%) were observed by epifluorescence
microscopy at the air–water interface. Fig. 8 shows a set of
Fig. 8. Fluorescence microscopy images of monolayers at 6 mN/m (A) and 8 mN/m (B). (1) DPPC:NBD-PC (99.5:0.5), (2) DPPC:NBD-PC:UQ2 (94.5:0.5:5), (3)
DPPC:NBDPC: UQ4 (94.5:0.5:5), (4) DPPC:NBD-PC:UQ6 (94.5:0.5:5), (5) DPPC:NBD-PC:UQ10 (94.5:0.5:5).
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94.5:0.5:5 on pure water were compressed at the same rate
without interruption for video recording.
At surface pressures near to zero, images observed for all the
monolayers consist of dark circular “bubbles” of 2D gas in the
bright field of the liquid-expanded (LE) phase (data not shown).
At low pressures (1–5 mNm−1), pure DPPC monolayers
showed the homogeneous fluorescent LE phase due to a resultof dye partitioning. In mixed DPPC:UQ monolayers, the bright
field of the less ordered LE phase persists at higher surface
pressures as the mole fraction of ubiquinone increased. Then, as
surface pressure is increased further in monolayers, transition
into liquid-condensed phase occurs, indicated by the appearance
of dark LC domains. Indeed, the condensed phase is dark since
the dye is excluded from the ordered domains due to steric
hindrance. These domains were relatively homogenous in shape
Fig. 9. Fluorescence microscopy of monolayers: total percentage of dark (probe excluded) regions per frame, plotted as a function of surface pressure for: (○) pure
DPPC, (■) 1 mol% UQ, (△) 5 mol% UQ, (▾) 10 mol% UQ, with 0.5 mol% NBD-PC.
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LC phase transition occurred in mixed monolayers and had
features similar to those seen in pure DPPC films (see Fig. 8).
The presence of 5 mol% ubiquinone decreases the LC domain
size and a change in shape is observed, compared with pure
DPPC at equivalent surface pressures, as shown in Fig. 8. These
features are associated with an overall decrease of the total area
occupied by the LC domains, as quantified in Fig. 9.
Fig. 9 shows a plot of percentages of LC domain, i.e., (total
area of the condensed domains/total area of the frame)×100,
versus surface pressure for DPPC containing 0 to 10 mol%
ubiquinone. Each dataset presented contains the whole data of
three independent experiments (i.e., three different mono-
layers), with images took at various surface pressures. With this
procedure, standard deviations of the calculated proportions of
condensed area are given by the systematic error due to pre-
processing and threshold adjustment and are estimated at ±3%.
Pure DPPC monolayer begins to condense near 5 mNm−1
and condensed domains occupy over 60% of the total area near
6 mNm−1. In monolayers containing 5–10 mol% ubiquinones,
dark regions were initially observed at higher surface pressures,especially in the case of DPPC:UQ-10 mixtures; at 10 mol%
condensation started at ∼8 mNm−1. Moreover, the images seen
at 8 mNm−1 in Fig. 8 (B2 to B5) showed condensed domains
having multilobe shapes as those observed in DPPC film
compressed at the same rate to 6 mNm−1 (A1).
4. Discussion
While there are several reports on UQ organization in bilayers,
this is the first systematic study on the thermodynamic behavior of
mixedmonolayers ofDPPCand ubiquinoneswith polyisoprenoid
chain length varying from 2 to 10 isoprene units. DPPC has been
selected for this investigation since a well-defined LE-LC phase
transition is observed during compression. Thus, it was possible
to study the influence of the UQ chain length on this DPPC phase
transition by epifluorescence microscopy.
4.1. Behavior of pure UQ monolayers
As the length of the side-chain decreases, the collapse pres-
sure of UQ monolayers decreases. To some extent, the behavior
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acids and must be related to a shift in the balance of hydro-
phobic to hydrophilic character of the molecule in favor of
greater polarity. Indeed, this behavior can be rationalized in
terms of competition of two major factors: the effect of a re-
latively polar headgroup and the presence of an hydrophobic
isoprenoid tail. The longer the chain is, the greater the hydro-
phobic properties are. The cyclohexane/water partition coeffi-
cients and the retention times in HPLC analysis of different
ubiquinones known from literature [49,50] are good parameters
of their hydrophobicity. It was observed that each isoprene unit
increases the partition coefficient by approximately 2.5 orders
of magnitude and causes more pronounced changes in the re-
tention times for long homologues in comparison to the short
quinones. Thus, the lateral chain length governs directly the
hydrophobic/hydrophilic balance of ubiquinones and the col-
lapse point is a good marker of their hydrophobicity. However,
after the collapse point, all UQ films remain very stable for
several hours, in contrast with fatty acids [51]. This difference
is probably correlative to the nature of the headgroup: the
packing of benzoquinone rings can certainly stabilize the
monolayers.
UQ4 andUQ6, with middle long chains, formmonolayers the
less sensitive to loss of material upon compression. UQ2 with
the shortest hydrophobic tail (only 10 carbon atoms), and UQ10
with the longest one, are squeezed out more easily from the films
during compression. Comparison with fatty acids helps to clarify
the nature of material loss. Indeed, the water solubility of fatty
acids decreases as the alkyl chain increases. To obtain an in-
solublemonolayer of a non-ionized fatty acid, the molecule must
contain at least twelve carbon atoms [52]. In our cases, the
shortest ubiquinone, UQ2, cannot maintain at the air/water in-
terface due to its weak hydrophobicity and then dissolves into
the water subphase. In contrast, longer derivatives must be
gradually expelled above the monolayer. This is the case of the
longest derivative, UQ10, which contains an isoprenoid chain
that when fully extended is more than twice the length of the
fatty acyl residues of a DPPC molecule and forms monolayers
with the lowest collapse pressure.
In addition, the molecular area occupied by UQ at a given
surface pressure increases with the side chain length. It is
noteworthy that each isoprene unit contains an insaturation in
position 2 and a branched methyl group in position 3. Inter-
estingly, films of branched/unsaturated fatty acids tend to be
expanded rather than condensed, compared with saturated/un-
branched fatty acids [46]. Then, as in the case of unsaturated and/
or branched fatty acids [52], isoprenoid chains disturb close
packing in UQmonolayers, the expansion of the film depending
on chain length too.
4.2. Mixed UQ:DPPC monolayers
Based on the composition-dependent collapse surface
pressures, it can be concluded that DPPC and UQn were totally
or partially miscible at the air/water interface except for mix-
tures containing more than 50 mol% UQ10. The presence of
UQn in DPPC monolayers disturbs the packing of DPPCmolecules in a nonideal way, and results in the formation of a
biphasic system with positive deviations in Aex which are more
pronounced as the isoprenoid chain is longer. This behavior can
be explained by the difference in the side chain lengths of both
components in the mixed monolayers, side-chains of UQ6 and
UQ10 being longer than the hydrocarbon chains of DPPC.
Indeed, the parts of UQ6 or UQ10 molecules which protrude
from the monolayer can freely rotate over phospholipid mole-
cules and strongly interact by steric repulsions in ubiquinones-
rich microdomains, due to insaturations and branched methyl
groups. Thus, the space occupied by UQ6 or UQ10 chains in-
creases the average molecular area. The highest deviation should
then occurs at equal amount ofDPPC andUQmolecules,which is
consistent with the experimental data obtained (Fig. 6). To explain
this Aex= f (XUQ) profile, we propose, as stated before, that the
relative organization of the two components remains unchanged
whatever their proportion. A convenient model would be that, as
the long-chain ubiquinones molar fraction increases, the number
of UQn-rich microdomains increases, their size remaining
unchanged. Hence, with this microdomains constant size
model, we can explain why the quantity of individual interactions
between the two components depends only on their relative pro-
portion. The length of the fully extended UQ4 is approximately
the same as the DPPC when both the molecules are oriented
vertically in the film, whereas the length of UQ2 side-chain is
shorter. However, at 10 mNm−1, the mean molecular area is still
higher than that of ideallymixed components, indicating thatUQ2
and UQ4 do no pack ideally between the hydrocarbon chains of
the phospholipids, but form UQn-rich microdomains. As stated
before, the asymmetry of the Aex= f (XUQ) profile in case of short-
chain ubiquinones suggests that DPPC:UQn interactions inmixed
films would be minimized by means of a change in the relative
organization of the two components, that results in a growth of the
UQn-rich microdomains size as the ubiquinone molar fraction
increases. This would be possible thanks to the nature of global
interactions between short-chain ubiquinones in UQn-rich
microdomains, where van der Waals attractions would be able
to compensate steric repulsions. It is interesting to note that at low
contents of ubiquinones (i.e., ≤10 mol%), the presence of UQ2
perturbs more the packing of DPPC molecules than UQ4. For 25
or more mol% ubiquinones, the excess area is higher with UQ4
than UQ2. This suggests that above this content, unsaturated and
non branched UQ2 chains allow more UQ chain–UQ chain van
der Waals interactions than the UQ4 isoprenoid tails, within UQ-
rich microdomains.
Moreover, the decrease of the excess area per molecule for
surface pressures higher than 10 mNm−1 could be interpreted in
two distinct ways: (i) as the surface pressure increases the
system can tend towards a total segregation, (ii) as π becomes
close to the collapse pressure, ubiquinones are gradually expelled
from the monolayer. However, explanation (ii) must be excluded
since gradual expulsion of UQ over compression would have
impliedΔGm decrease aswell. In addition, by plottingmixed films
isotherms as a function of the area per DPPC molecule (Fig. 4), it
can be seen that ubiquinones seem largely excluded from mono-
layers only for surface pressures widely larger than the collapse
pressure of the pure UQn, which is the limiting data to calculate
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account for the expulsion of ubiquinones from monolayers. The
hypothesis (i) is not either fully satisfactory, since the composition-
dependence of collapse surface pressures noticed in the previous
section (Fig. 5) does not argue for total segregation, even if the
positive ΔGex values are nevertheless compatible with. Thus, the
system must tend towards a more marked segregation, the mi-
crodomains being certainly more and more pure as the pressure
increases. However, the total lateral segregation is never reached
because film collapse occurs before it can be effective. Similar to
pure ubiquinones monolayers, this film collapse could mainly
result in the formation of a disordered UQn-rich phase overlying
the system. With DPPC:UQ2 mixtures dissolution of the ubi-
quinone into the water subphase could be envisaged.
Fluorescence microscopy has been used in studying mixed
monolayers. Systematically the higher the proportion of ubi-
quinone, the lower the percentage of LC domains are observed at
higher surface pressures. Increasing amounts of ubiquinone
resulted in a decreased amount of probe-excluded regions even at
high surface pressures, i.e., favoring the existence of continuous
bright field. Thus, ubiquinones seem to be preferentially soluble
in this continuous phase. Ubiquinones disrupt DPPC packing and
decrease the size of the dark ordered condensed domains while
increasing that of the disordered phase. Longer is the isoprenoid
chain more pronounced is the effect.
The condensed domains observed in mixed monolayers at
8 mNm−1 show multilobe shapes as those observed in DPPC
film at 6mNm−1. This observationwould tend to suggest that the
condensed domains of mixed DPPC:UQn films may be made of
the main component, the DPPC. Consequently, miscibility of
DPPC and UQ could be assumed to decrease when condensed
regions become majority. This is coherent with previous results
showing that deviations from ideality are strongly increased in
the corresponding surface pressure range.
In conclusion, when mixed with DPPC, ubiquinones exhibit
distinct lateral organizations, depending also on the length of side-
chain. Long-chain ubiquinones (UQ6 and UQ10) are self-
organized within UQn-rich constant-size microdomains, while
short-chain ubiquinones (UQ2 and UQ4) form microdomains
able to grow as the ubiquinone concentration increases. Over 2D
compression, the system tends to a total DPPC/UQ lateral
segregation, ubiquinones being preferentially soluble in the
continuous expanded phase. However, this total segregation is
never reached due to transversal expulsion of film compounds,
mainly ubiquinones. Similarly to pure ubiquinone films, collapse
surface pressure of DPPC:UQ mixed films depends on the side-
chain length too. Expulsion occurs for surface pressures as low
as the lateral chain is long and may result in the formation of a
disordered UQn-rich phase overlying the monolayer.
Our study gives strong evidence for an influence of isoprenoid
chain length on both the lateral organization and the transversal
expulsion of ubiquinones within DPPC:UQ monolayers.
4.3. Outlook
Although some concentrations used in this study are higher
than in the native systems, the results can give us some in-formation about the influence of the chain length on the
orientation of ubiquinones in membranes, bearing in mind the
limitations of an analogy between a monolayer model system
and the biological membrane.
Thus, chain-length effects occurring in model membranes
could be related with previously described differences on bio-
logical actions and therapeutic effects from short-chain exo-
genous derivatives compared to natural human UQ10. Our results
support a preferential midplane location of UQ10 in biological
membranes, whereas, in similar conditions, short-chain (UQ2,
UQ4) exogenous derivatives would be able to remain oriented
parallel to the chains of the phospholipids with their quinone
domains in the region of the phospholipids headgroup. This
conclusion is supported by many authors having studied
ubiquinones localizationwithin phospholipids bilayers by various
techniques [32–36,38–41]. In addition, according to our model, it
is proposed that lateral organization of UQ10 and short-chain
derivatives in membranes would be different: respectively, (i)
formation of an increasing number of ubiquinones-rich micro-
domains of a limited size, and (ii) organization of UQ analogues
within less growth limited microdomains. Such a lateral
organization of UQn-rich domains supports the distribution of
ubiquinone in separate and distinct pools within biological
membranes as previously suggested [53]. One can propose
exogenous short-chain analogues to form larger pools than natural
UQ10 molecules, in the same physiological conditions, that
would be of great significance for some specific biological roles,
especially when interactions with other functional lipids or
membrane proteins are involved. This assumption is supported by
some studies that have shown that mitochondrial complex I has
two distinct anchoring sites for short and long chain ubiquinones
[28–30]. Such functional specificity of short-chain ubiquinones
could be correlated to their noteworthy therapeutic efficiency [27]
and argue for isoprenoid chain length to be an essential tune able
parameter for new drugs design.References
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